Edwards Lifesciences
1,248 hedge funds and large institutions have $39.2B invested in Edwards Lifesciences in 2025 Q2 according to their latest regulatory filings, with 165 funds opening new positions, 416 increasing their positions, 455 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.49% more ownership
Funds ownership: 85.07% → 85.55% (+0.49%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
9% less repeat investments, than reductions
Existing positions increased: 416 | Existing positions reduced: 455
Holders
1,248
Holding in Top 10
10
Calls
$254M
Puts
$149M
Top Buyers
| 1 | +$376M | |
| 2 | +$376M | |
| 3 | +$302M | |
| 4 |
Millennium Management
New York
|
+$253M |
| 5 |
Jennison Associates
New York
|
+$124M |
Top Sellers
| 1 | -$765M | |
| 2 | -$728M | |
| 3 | -$415M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$126M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$82.1M |
